expression of hereditary hemochromatosis promoter polymorphisms influence the phenotypic α Tumor necrosis factor
暂无分享,去创建一个
L. N. Valenti | M. Mattioli | S. Fargion | G. Fiorelli | P. Dongiovanni | A. Scaccabarozzi | M. Sampietro
[1] J. Steer,et al. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. , 2000, Cytokine.
[2] M. Linder,et al. Secretion of Ferritin by Rat Hepatoma Cells and Its Regulation by Inflammatory Cytokines and Iron , 1997 .
[3] Schneider,et al. A tumour necrosis factor‐alpha (TNF‐α) promoter polymorphism is associated with chronic hepatitis B infection , 1998 .
[4] L. Powell,et al. Haemochromatosis in the new millennium. , 2000, Journal of hepatology.
[5] D. Banerjee,et al. Ferritin release by mononuclear cells in hereditary hemochromatosis. , 1989, The Journal of laboratory and clinical medicine.
[6] D. Conte,et al. Response of monocyte iron regulatory protein activity to inflammation: abnormal behavior in genetic hemochromatosis. , 1998, Blood.
[7] D. Kwiatkowski,et al. Association of a Tumour Necrosis Factor Promoter Polymorphism with Susceptibility to Pulmonary Tuberculosis , 1996 .
[8] D. Girelli,et al. Heterogeneity of hemochromatosis in Italy. , 1998, Gastroenterology.
[9] A. Blakemore,et al. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. , 1992, Human molecular genetics.
[10] D. Girelli,et al. The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients , 1996, Hepatology.
[11] M. Manns,et al. The tumor necrosis factor-α promoter correlates with progression of primary biliary cirrhosis , 1999 .
[12] M. J. Page,et al. γδ intraepithelial lymphocytes drive tumor necrosis factor‐α responsiveness to intestinal iron challenge: relevance to hemochromatosis , 1999 .
[13] F. Torti,et al. Tumor necrosis factor-alpha and interleukin 1-alpha regulate transferrin receptor in human diploid fibroblasts. Relationship to the induction of ferritin heavy chain. , 1991, The Journal of biological chemistry.
[14] J. Grove,et al. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis , 1997, Hepatology.
[15] G. Gerken,et al. Tumor necrosis factor alpha promoter polymorphism at position ‐238 is associated with chronic active hepatitis C infection , 1998, Journal of medical virology.
[16] P. Donaldson,et al. Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracetamol)-induced acute liver failure. , 1998, Journal of hepatology.
[17] L. Abraham,et al. The −308 tumor necrosis factor-α promoter polymorphism effects transcription , 1997 .
[18] F. Pociot,et al. Functional Analysis of a New Polymorphism in the Human TNF α Gene Promoter , 1995, Scandinavian journal of immunology.
[19] H. Mcdevitt,et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[20] K. Taylor,et al. Donor polymorphism of tumor necrosis factor gene: relationship with variable severity of hepatitis C recurrence after liver transplantation. , 1999, Transplantation.
[21] L. N. Valenti,et al. Relationship between TNF‐α and iron metabolism in differentiating human monocytic THP‐1 cells , 2000 .
[22] L. Moldawer,et al. Cachectin/tumor necrosis factor‐α alters red blood cell kinetics and induces anemia in vivo , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] P. Galle,et al. Different Transcriptional Activity and In Vitro TNF-α Production in Psoriasis Patients Carrying the TNF-α 238A Promoter Polymorphism , 2000 .
[24] F. Torti,et al. Iron-independent induction of ferritin H chain by tumor necrosis factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[25] Y. Kohgo,et al. Regulation of iron metabolism in HepG2 cells: A possible role for cytokines in the hepatic deposition of iron , 1993, Hepatology.
[26] D. Conte,et al. Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. , 1997, Blood.
[27] S. Young,et al. Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA. , 1993, The Biochemical journal.
[28] K. Myambo,et al. The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene. , 1988, The Journal of biological chemistry.
[29] P. Donaldson,et al. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis , 1999, Hepatology.
[30] M. C. Ellis,et al. A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.
[31] J. Newton,et al. Tumour necrosis factor-a promoter polymorphisms in primary biliary cirrhosis , 1999 .
[32] M. Colombo,et al. Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis. , 2000, Blood.
[33] J. Olynyk,et al. A population-based study of the clinical expression of the hemochromatosis gene. , 1999, The New England journal of medicine.
[34] N. Hayashi,et al. Delayed fas‐mediated hepatocyte apoptosis during liver regeneration in mice: hepatoprotective role of TNFα , 1998, Hepatology.
[35] P. Brissot. The discovery of the new haemochromatosis gene , 2003 .
[36] A. R. Muir,et al. Hepatic pathology in relatives of patients with haemochromatosis. , 1962, The Journal of pathology and bacteriology.
[37] S. Sherlock,et al. Measurement of liver-iron concentration in needle-biopsy specimens. , 1971, Lancet.
[38] S. D'alfonso,et al. A polymorphic variation in a putative regulation box of the TNFA promoter region , 2004, Immunogenetics.
[39] J. Brock,et al. Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. , 1989, Laboratory investigation; a journal of technical methods and pathology.